Premature Ejaculation - Pipeline Review, H2 2014 th
On 10 October 2014
Summary Premature Ejaculation - Pipeline Review, H2 2014, provides an overview of the Premature Ejaculations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Premature Ejaculation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Premature Ejaculation and special features on late-stage and discontinued projects.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcare-medical/rpremature-ejaculation-pipeline-review-h2-2014-126946 Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope - The report provides a snapshot of the global therapeutic landscape of Premature Ejaculation - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Premature Ejaculation and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Premature Ejaculation products under development by companies and universities/research institutes based on information derived from company and industryspecific sources - Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Premature Ejaculation pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products
Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Premature Ejaculation - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Premature Ejaculation pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Table of Content List of Tables 4 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Premature Ejaculation Overview 7 Therapeutics Development 8 Pipeline Products for Premature Ejaculation - Overview 8 Pipeline Products for Premature Ejaculation - Comparative Analysis 9 Premature Ejaculation - Therapeutics under Development by Companies 10 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Premature Ejaculation - Pipeline Products Glance 12 Late Stage Products 12 Clinical Stage Products 13 Early Stage Products 14 Premature Ejaculation - Products under Development by Companies 15 Premature Ejaculation - Companies Involved in Therapeutics Development 16 Allergan, Inc. 16 SK Chemicals Co., Ltd. 17 Yungjin Pharm Ind. Co., Ltd. 18 Plethora Solutions Holdings plc 19 NeuroHealing Pharmaceuticals Inc. 20 Furiex Pharmaceuticals, Inc. 21 Dong-A Socio Group 22 Premature Ejaculation - Therapeutics Assessment 23 Assessment by Monotherapy Products 23 Assessment by Combination Products 24 Assessment by Target 25 Assessment by Mechanism of Action 27 Assessment by Route of Administration 29 Assessment by Molecule Type 31 Drug Profiles 33 tramadol hydrochloride - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 (lidocaine + prilocaine) - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 dapoxetine hydrochloride - Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 tramadol hydrochloride - Drug Profile 40 Product Description 40 Mechanism of Action 40 R&D Progress 40 onabotulinumtoxin A - Drug Profile 43 Product Description 43 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Mechanism of Action 43 R&D Progress 43 DA-8031 - Drug Profile 45 Product Description 45 Mechanism of Action 45 R&D Progress 45 IX-01 - Drug Profile 46 Product Description 46 Mechanism of Action 46 R&D Progress 46 modafinil - Drug Profile 47 Product Description 47 Mechanism of Action 47 R&D Progress 47 NCE-405 - Drug Profile 48 Product Description 48 Mechanism of Action 48 R&D Progress 48 YPE-1706 - Drug Profile 49 Product Description 49 Mechanism of Action 49 R&D Progress 49 Premature Ejaculation - Recent Pipeline Updates 50 Premature Ejaculation - Dormant Projects 57 Premature Ejaculation - Discontinued Products 58 Premature Ejaculation - Product Development Milestones 59 Featured News & Press Releases 59 May 15, 2014: Innovus Pharma Announces the Beginning of Patient Enrollment in Its PostMarketing EjectDelay Clinical Study in the Middle East 59 Mar 26, 2014: Plethora Solutions Announces Manufacturing Appointment 59 Mar 11, 2014: Plethora Solutions Provides Company update 60 Dec 06, 2013: Innovus Pharma Receives Product License Approval of EjectDelay for Premature Ejaculation From Health Canada 61 Nov 19, 2013: Plethora Solutions Receives European Commission Approval For PSD502 To Treat Premature Ejaculation 61 Oct 31, 2013: Furiex Pharmaceuticals Announces Priligy Launch in the United Kingdom by Menarini 62 Oct 29, 2013: Innovus Pharma Files Its Product License Application for Commercialization of EjectDelay for Premature Ejaculation in Canada 62 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Sep 19, 2013: Plethora Solutions Receives CHMP Positive Opinion For Lidocaine/Prilocaine Plethora For Treatment Of Primary Premature Ejaculation 62 Jul 01, 2013: AGM Statement & PSD502 Regulatory Update 63 Jun 03, 2013: Ampio Pharma Provides Update On Sexual Dysfunction Portfolio 64 Appendix 65 Methodology 65 Coverage 65 Secondary Research 65 Primary Research 65 Expert Panel Validation 65 Contact Us 66 Disclaimer 66 List Of Tables Number of Products under Development for Premature Ejaculation, H2 2014 8 Number of Products under Development for Premature Ejaculation - Comparative Analysis, H2 2014 9 Number of Products under Development by Companies, H2 2014 11 Comparative Analysis by Late Stage Development, H2 2014 12 Comparative Analysis by Clinical Stage Development, H2 2014 13 Comparative Analysis by Early Stage Development, H2 2014 14 Products under Development by Companies, H2 2014 15 Premature Ejaculation - Pipeline by Allergan, Inc., H2 2014 16 Premature Ejaculation - Pipeline by SK Chemicals Co., Ltd., H2 2014 17 Premature Ejaculation - Pipeline by Yungjin Pharm Ind. Co., Ltd., H2 2014 18 Premature Ejaculation - Pipeline by Plethora Solutions Holdings plc, H2 2014 19 Premature Ejaculation - Pipeline by NeuroHealing Pharmaceuticals Inc., H2 2014 20 Premature Ejaculation - Pipeline by Furiex Pharmaceuticals, Inc., H2 2014 21 Premature Ejaculation - Pipeline by Dong-A Socio Group, H2 2014 22 Assessment by Monotherapy Products, H2 2014 23 Assessment by Combination Products, H2 2014 24 Number of Products by Stage and Target, H2 2014 26 Number of Products by Stage and Mechanism of Action, H2 2014 28 Number of Products by Stage and Route of Administration, H2 2014 30 Number of Products by Stage and Molecule Type, H2 2014 32 Premature Ejaculation Therapeutics - Recent Pipeline Updates, H2 2014 50 Premature Ejaculation - Dormant Projects, H2 2014 57 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Premature Ejaculation - Discontinued Products, H2 2014 58 List Of Figures Number of Products under Development for Premature Ejaculation, H2 2014 8 Number of Products under Development for Premature Ejaculation - Comparative Analysis, H2 2014 9 Number of Products under Development by Companies, H2 2014 10 Comparative Analysis by Late Stage Development, H2 2014 12 Comparative Analysis by Early Stage Products, H2 2014 14 Assessment by Monotherapy Products, H2 2014 23 Number of Products by Top 10 Target, H2 2014 25 Number of Products by Stage and Top 10 Target, H2 2014 26 Number of Products by Top 10 Mechanism of Action, H2 2014 27 Number of Products by Stage and Top 10 Mechanism of Action, H2 2014 28 Number of Products by Top 10 Route of Administration, H2 2014 29 Number of Products by Stage and Top 10 Route of Administration, H2 2014 30 Number of Products by Top 10 Molecule Type, H2 2014 31 Number of Products by Stage and Top 10 Molecule Type, H2 2014 32
Report Price: Licence Type
Price
$ 2000
Site Licence
$ 4000
Enterprise Wide Licence
$ 6000
Related Reports: PharmaNova Inc. - Product Pipeline Review - 2014 ContraFect Corporation - Product Pipeline Review - 2014 Five Prime Therapeutics, Inc. - Product Pipeline Review - 2014 AltraVax Inc. - Product Pipeline Review - 2014 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Vitiligo - Pipeline Review, H2 2014 Secondary Hyperparathyroidism - Pipeline Review, H2 2014 House Dust Mite Allergy - Pipeline Review, H2 2014 Pulmonary Tuberculosis - Pipeline Review, H2 2014 Post Menopausal Osteoporosis - Pipeline Review, H2 2014 Hairy Cell Leukemia - Pipeline Review, H2 2014
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Premature Ejaculation - Pipeline Review, H2 2014 http://www.jsbmarketresearch.com/healthcare-medical/r-prematureejaculation-pipeline-review-h2-2014-126946
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/